Candia, Jimboy M.

HRN: 20-48-83  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/09/2023
01/16/2023
IV
500mg
Q8
Soft Tissue Mass, Abcess(?) Right Parietal Are
Waiting Final Action 
01/09/2023
OXACILLIN 500MG (VIAL)
01/09/2023
01/16/2023
IV
275mg
Q6
Soft Tissue Abscess, Parietal Area Right
Waiting Final Action 
01/15/2023
CEFTRIAXONE 1G (VIAL)
01/15/2023
01/22/2023
IVTT
1.1g
Q24
PCAP
Waiting Final Action 
01/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/15/2023
01/22/2023
IVTT
165mg
Q24
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: